CLASS II Drug recall · Reported 22 Jan 2014 · FDA Enforcement Report

Phosphorus Tablet, 250 mg recalled by Aidapak Services

Aidapak Services is recalling Phosphorus Tablet, 250 mg, distributed in Arizona, California, Oregon, Washington. The recall was initiated on 2 Jul 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPHOSPHORUS Tablet, 250 mg has the following codes Pedigree: AD56916_1, EXP: 5/21/2014; Pedigree: W002534, EXP: 6/3/2014; Pedigree: AD25452_7, EXP: 5/3/2014; Pedigree: AD54498_1, EXP: 5/20/2014; Pedigree: W003997, EXP: 7/1/2014; Pedigree: AD46300_8, EXP: 5/15/2014; Pedigree: AD70639_10, EXP: 5/29/2014.
Quantity recalled1,000 Tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-699-2014
FDA event ID
65707
Recalling firm
Aidapak Services, Vancouver, WA
Classification
Class II
Status
Terminated
Recall initiated
2 Jul 2013
FDA classified
16 Jan 2014
Reported
22 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Labeling Errors

Timeline

2 Jul 2013Recall initiated by company
16 Jan 2014Classified by FDA+198 days
22 Jan 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014; VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014; NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014; traZODone HCl, Tablet, 50 mg, NDC 50111043303, P

Product as listed by the FDA

PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401

Where it was distributed

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

ArizonaCaliforniaOregonWashington

Questions about this recall

Is Phosphorus Tablet, 250 mg recalled?

Yes. Aidapak Services recalled Phosphorus Tablet, 250 mg on 2 Jul 2013. The recall is Class II and its status is Terminated. Recall number D-699-2014.

Why was it recalled?

Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014; VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014; NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014; traZODone HCl, Tablet, 50 mg, NDC 50111043303, P

Which lots are affected?

PHOSPHORUS Tablet, 250 mg has the following codes Pedigree: AD56916_1, EXP: 5/21/2014; Pedigree: W002534, EXP: 6/3/2014; Pedigree: AD25452_7, EXP: 5/3/2014; Pedigree: AD54498_1, EXP: 5/20/2014; Pedigree: W003997, EXP: 7/1/2014; Pedigree: AD46300_8, EXP: 5/15/2014; Pedigree: AD70639_10, EXP: 5/29/2014.

Where was it sold?

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aidapak Services

All 538